Pharmx Technologies Limited

ASX:PHX Stock Report

Market Cap: AU$56.6m

Pharmx Technologies Management

Management criteria checks 1/4

Pharmx Technologies' CEO is Tom Culver, appointed in Nov 2023, has a tenure of 2.83 years. total yearly compensation is A$693.81K, comprised of 51.4% salary and 48.6% bonuses, including company stock and options. directly owns 0.043% of the company’s shares, worth A$24.28K. The average tenure of the management team and the board of directors is 1.8 years and 5.9 years respectively.

Key information

Tom Culver

Chief executive officer

AU$693.8k

Total compensation

CEO salary percentage51.42%
CEO tenure2.8yrs
CEO ownership0.04%
Management average tenure1.8yrs
Board average tenure5.9yrs

Recent management updates

Recent updates

Analysis Article • Sep 01

Pharmx Technologies (ASX:PHX) Is In A Good Position To Deliver On Growth Plans

We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made...
Analysis Article • Feb 12

What Is PharmX Technologies Limited's (ASX:PHX) Share Price Doing?

PharmX Technologies Limited ( ASX:PHX ), is not the largest company out there, but it received a lot of attention from...
Analysis Article • Jul 12

A Look At The Intrinsic Value Of Corum Group Limited (ASX:COO)

Key Insights The projected fair value for Corum Group is AU$0.046 based on 2 Stage Free Cash Flow to Equity Current...
Analysis Article • May 11

At AU$0.044, Is Corum Group Limited (ASX:COO) Worth Looking At Closely?

Corum Group Limited ( ASX:COO ), might not be a large cap stock, but it saw a significant share price rise of over 20...
Analysis Article • Nov 12

Is Now The Time To Put Corum Group (ASX:COO) On Your Watchlist?

Like a puppy chasing its tail, some new investors often chase 'the next big thing', even if that means buying 'story...
Analysis Article • Apr 29

At AU$0.089, Is It Time To Put Corum Group Limited (ASX:COO) On Your Watch List?

Corum Group Limited ( ASX:COO ), might not be a large cap stock, but it saw a decent share price growth in the teens...
Analysis Article • Mar 02

Corum Group (ASX:COO) Is Posting Healthy Earnings, But It Is Not All Good News

Despite posting strong earnings, Corum Group Limited's ( ASX:COO ) stock didn't move much over the last week. We looked...
Analysis Article • Dec 13

Corum Group Limited (ASX:COO) Is Going Strong But Fundamentals Appear To Be Mixed : Is There A Clear Direction For The Stock?

Corum Group's (ASX:COO) stock is up by a considerable 96% over the past three months. But the company's key financial...

CEO Compensation Analysis

How has Tom Culver's remuneration changed compared to Pharmx Technologies's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2026AU$694kAU$357k

-AU$2m

Mar 31 2026n/an/a

-AU$1m

Dec 31 2025n/an/a

-AU$931k

Sep 30 2025n/an/a

-AU$597k

Jun 30 2025AU$514kAU$343k

-AU$264k

Mar 31 2025n/an/a

-AU$125k

Dec 31 2024n/an/a

AU$14k

Sep 30 2024n/an/a

AU$55k

Jun 30 2024AU$219kAU$191k

AU$95k

Compensation vs Market: Tom's total compensation ($USD499.51K) is above average for companies of similar size in the Australian market ($USD342.11K).

Compensation vs Earnings: Tom's compensation has increased whilst the company is unprofitable.

CEO

Tom Culver

2.8yrs
Tenure
AU$693,814
Compensation

Mr. Thomas Culver, also known as Tom, served as Head of Wealth & Crypto Services at Stakk Limited (formerly known as Douugh Limited) since January 2021. Mr. Culver is Goodments Founder & CEO. Mr. Culver is...

Leadership Team

NamePositionTenureCompensationOwnership
Thomas Culver
Chief Executive Officer2.8yrsAU$693.81k0.043%
A$ 24.3k
Zoe Hillier
Chief Financial Officer5.2yrsAU$266.84k0.094%
A$ 53.1k
Andrew Jonathan Newbery
COO & Executive Directorno dataAU$300.55k0.26%
A$ 145.6k
Alistair Orchard
CTOno datano datano data
Vaughan Ryan
Chief Revenue Officerless than a yearno datano data
Taufiq Khan
Chief Product Officerless than a yearno datano data
Christopher Fernandes
Company Secretary1.8yrsno datano data
1.8yrs
Average Tenure

Experienced Management: PHX's management team is not considered experienced ( 1.8 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Andrew Jonathan Newbery
COO & Executive Director6.6yrsAU$300.55k0.26%
A$ 145.6k
Jayne Shaw
Independent Non-Executive Director5.9yrsAU$98.56k0.42%
A$ 236.4k
Philip England
Non-Executive Chairman6.8yrsAU$143.36k4.02%
A$ 2.3m
Mark Conway
Non-Executive Directorless than a yearno datano data
Alexander Mellis
Non-Executive Director1yrAU$92.96kno data
5.9yrs
Average Tenure

Experienced Board: PHX's board of directors are considered experienced (5.9 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/09/10 01:15
End of Day Share Price 2026/09/10 00:00
Earnings2026/06/30
Annual Earnings2026/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Pharmx Technologies Limited is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Caleb WengPAC Partners Securities Pty. Ltd.